Concepedia
Statistics
Publications
8
Citations
316
H-Index
Active since
2006
Affiliations
Orano (France)(Current)
Centre National de la Recherche Scientifique
Inserm
RadioMedix (United States)
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Amal Saidi is an author at Orano (France) specializing in medicine, pharmacology, and oncology.
Publications per year
2006–2024
Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double‐strand breaks
Yun-Gui Yang, Amal Saidi, Pierre‐Olivier Frappart et al. · The EMBO Journal · 2006 · 82 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model
Tania A. Rozgaja Stallons, Amal Saidi, Izabela Tworowska et al. · Molecular Cancer Therapeutics · 2019 · 76 citations · Full text
Medicine, Nuclear Medicine, Pharmacology +17
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
Astri Fjelde Maaland, Amal Saidi, Julien Torgue et al. · PLoS ONE · 2020 · 39 citations · Full text
Medicine, Oncology, Pharmacology +17
<sup>212</sup>Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
Isabelle Quelven, Jacques Monteil, Magali Sage et al. · Journal of Nuclear Medicine · 2019 · 38 citations · Full text
Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma
Stéphanie Durand-Panteix, Jacques Monteil, Magali Sage et al. · British Journal of Cancer · 2021 · 27 citations · Full text
Medicine, Immunology, Oncology +12
1–5 of 8